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ABSTRACT 
Objective: The uses of medicinal herbs in prevention and treatment of numerous diseases attracting attention of scientists worldwide. It is 
necessary to bring vital healthcare to the people and the better substitute for various infectious diseases. Ruta graveolens is traditionally used as a 
medicinal plant as well as a flavoring agent in food. In the present study R. graveolens leaves extracts were evaluated for phytochemical and anti-
inflammatory activity. 
Methods: The phytochemical, antioxidant (DPPH), ferrous reducing antioxidant property, Anti-lipid peroxidation and superoxide scavenging 
activity of extracts were assayed by spectrophotometerically. Anti-inflammatory activities; Human plural fluid phospholipase A2 (HPF-PLA2) 
inhibition by egg yolk plate method and lipoxigenase (LOX) inhibition were assayed by IN VITRO method. 
Results: The phenolics were significantly higher than the flavonoids, saponins and alkaloids contents in all the extracts. Among extracts of R. 
graveolens, ethanol and water extracts exhibits more phytochemicals. The ethanol extract had the highest antioxidant activity followed by the 
aqueous extract. The ethanol extract shows highest DPPH free radical scavenging, ferric reducing, superoxide scavenging and anti-lipid peroxidation 
activity and IC50 was 3.27±0.03, 3.58±0.05, 3.87±0.04 and 4.77±0.04 µg/µl respectively at dose-dependent manner. Further ethanol and water 
extracts were subjected for LOX inhibition in the concentration dependent manner and IC50 values are 4.25±0.05, 5.15±0.05 µg/µl for 5-LOX and 
4.15±0.04, 4.66±0.05 µg/µl for 15-LOX respectively. 
Conclusion: The result shows R. graveolens has strong antioxidant property and anti-inflammatory activity. It suggests that the strong correlation 
between antioxidant activity and the phytochemical contents of the extracts. 
Keywords: HPF, Human Pleural Fluid, Anti-inflammatory, sPLA2, Secretory Phospholipase A2, HPF-PLA2, Human Pleural Fluid-PLA2. LOX 
Lipoxigenase, Lipid peroxidation, Anti-inflammation. 
 
INTRODUCTION 
Plants are the local heritage with global importance. World is 
endowed with a rich wealth of medicinal plants. Plant extracts have 
been the source of remedy for various clinical abnormalities from 
the time immemorial. Over three quarters of the world population 
relies mainly on plant-based medicines for the primary health care 
[1]. Roughly more than 30% of the plant species have been used for 
therapeutic purposes and about 25% of all prescribed medicines 
using today are substances derived from plants. Many of these 
indigenous medicinal plants are used as spices and food plants [2]. 
They are sometimes added to foods meant for pregnant and nursing 
mothers for medicinal purposes [3]. The medicinal properties of 
herbal extracts are attributed to the presence of diverse classes of 
bio-active molecules, many of which have attained the level of drugs 
[4]. Phytochemicals are employed for the treatment of hypertension, 
cardiovascular disorders, cancer, neuronal disorders, inflammation, 
diabetes, malaria, influenza, arthritis, and severe pain [5]. 
Inflammation is a localized reaction that produces redness, warmth, 
swelling, and pain result in infection, irritation or injury. It contributes 
to all disease process including immunity, vascular pathology and 
leads to several undesirable consequences such as systemic shock, 
circulatory collapse and local tissue injury in many organs [6, 7]. 
Inflammation is mainly mediated by secretory phospholipase A2 
(sPLA2). Several snake venom PLA2 enzymes are responsible for local 
tissue damage such as edema and hemorrhage. Elevated level of sPLA2 
enzymes are detected in many inflammatory disorders [8, 9] and play 
a key role by releasing arachidonic acid and lysophospholipid, which 
are rate-limiting precursors for the production of pro-inflammatory 
lipid mediators. Cyclooxigenase-1/2 (COX-1/2) and lipoxigenase 
(LOX) catalyze arachidonic acid into pro-inflammatory mediators such 
as prostoglandins, thrombaxanes, and leukotriens respectively. 
Lysophospholipid is further converted into platelet activation factor 
(PAF) by acetyltransferase [10]. Further, Phospholipase A2 (PLA2) 
plays a crucial role in a number of diverse cellular as well as chemical 
and metabolic injuries. Apart, they involved in phospholipid digestion 
and metabolism, host defense, signal transduction and provide 
precursors for eicosanoid generation. 
Present anti-inflammatory therapies include the non-steroidal anti-
inflammatory drugs (NSAIDs) that inhibit either Cyclo-oxygenase-
1/2 (COX-1/2) or Lipoxygenase (LOX) catalysis have severe side 
effects such as intestinal ulceration, bleeding and cardiovascular 
complications [11]. In addition to these problems, COX-1/2 or LOX 
inhibitors cannot regulate the production of leukotrienes or PAF 
that continue to cause inflammation [12]. It appears rational that 
effective inhibitors of sPLA2 could deplete the sources of arachidonic 
acid and therefore its downstream metabolites and PAF would not 
affect the homeostasis of COX-1/2 and LOX enzymes.  
Therefore, the great demand for natural products for PLA2 inhibition 
rather than NSAIDs to treat inflammatory disorders. The literature 
survey showed that several endogenous and exogenous agents have 
been reported to inhibit sPLA2 enzymes [13]. In addition, several 
laboratories are synthesizing compounds to inhibit sPLA2 [14]. But 
none of them are made into the market, which demands researchers 
to look for new specific sPLA2 inhibitors. 
Ruta graveolens belonging to family Rutaceae has long been used 
traditional medicine for various ailments including hysteria, 
gastrointestinal disorders, and menstrual problems. The juice of fresh 
rue has been used to relieve toothaches and earaches. It has been 
reported to possess antifungal [15], antibacterial [16], anti-inflammatory 
[17], antitumour [18] and cytotoxic activities [19]. Although, no 
information available on the effect of R. graveolens on inflammatory 
enzymes. In the present study, effect of R. graveolens leaves ethanol and 
aqueous extract on LOX and sPLA2 activity was estimated.  
MATERIALS AND METHODS 
Diphenyl Picryl Hydrazyl radical (DPPH˙), Thiobarbituric acid, 
Quercetin, Gallic acid, were purchased from Sigma-Aldrich Chemical 
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Laboratories, St. Louis, MO, USA. Aluchrosep silica Gel 60/UV254 TLC 
plates were obtained from S D FINE CHEM. Limited, Mumbai. Human 
pleural fluid was obtained from Chest Disease Hospital, Mysore, India. 
Dimethyl sulphoxide (DMSO) from Merck and all other chemicals and 
reagents used in this study were of analytical grade or better. 
Preparation of plant extracts  
R. graveolens plants were collected from kodagu district, washed, 
fresh leaves were shade dried and powdered mechanically. The 
powder (75g) was subjected to soxhlet extraction with solvents such 
as hexane, benzene, chloroform, acetone, ethanol, methanol and 
water in the ratio of 75g/500 ml (w/v). The extracts of organic 
solvents were concentrated to powder by flash evaporator and 
water sample was reduced to powder by lyophilization. The yield 
was calculated and expressed as % w/w.  
Phytochemical analysis 
The concentration of total phenolics was estimated by the methods 
of Singleton [20] using Gallic acid as standard. The photochemical 
analysis of different solvents extracts of R. graveolens was done by 
the method described in Yusuf AZ. et. al [21]. TLC for all the extracts 
was eluted with solvent-n-hexane: ethyl acetate (8:2) and observed 
under UV light. 
Estimation of flavanoids  
The flavonoids were estimated calorimetrically using Quercetin to 
make the calibration curve [22]. 100μg/ml of Quercetin was 
prepared by dissolving 10 mg in 80% ethanol. The reaction mixture 
contains 1.5 ml of 95% ethanol, 0.1 ml of 10% aluminum chloride, 
0.1 ml of 1M potassium acetate and 2.8 ml of distilled water was 
incubated at room temperature for 30 min. The absorbance of the 
reaction mixture was measured at 415 nm. The aluminum chloride 
(10%) was substituted with distilled water in blank. Flavonoids in 
plant extract reacted with aluminum chloride was determined as 
described above.  
Reducing power assay  
The reducing power ability of extracts was determined by the method 
as described in Jayaprakash [23]. The reaction mixture contains, 
extract (100μg/ml) with equal volume of 0.2M phosphate buffer pH 
6.6 and potassium ferricyanide was incubated at 50o C for 20 min. 
Centrifuged at 3000 rpm for 10 min by adding equal volume of 
10%TCA to the mixture. To the upper layer, distilled water and 0.1% 
ferric chloride in a ratio of 1:1:2(v/v/v) were added. The absorbance 
was measured at 700 nm and increased absorbance of the reaction 
mixture compare to blank indicates increased reducing power activity. 
Superoxide radical scavenging 
The reduction of NBT was assayed according to Dasgupta [24]. 
Superoxide radicals generated by non-enzymatic phenazine 
methosulfate-nicotinamide adenine dinucleotide (PMS/NADH) 
system often reduce nitro blue tetrazolium (NBT) to a purple 
formazan. The 1 ml reaction mixture contains phosphate buffer (20 
mM, pH 7.4), NBT (50 μM), NADH (73 μM), PMS (15 μM) and plant 
extracts (100μg/ml). Incubate for 5 min at room temperature and 
the absorbance was measured at 562 nm against an appropriate 
blank to determine the quantity of formazan generated. Quercetin 
was used as positive control. 
Estimation of antioxidant activity 
Antioxidant activity of R. graveolens was determined using 2, 2-
Diphenyl-1-picryl hydrazyl radical (DPPH˙) as described by Blios 
[25]. Briefly, 100µg Extracts of R. graveolens were mixed with 5 ml of 
0.1 mM methanolic solution of DPPH and incubated at 20°C for 20 
min in complete dark. The DPPH alone serves as control and 
methanol were used for the base line correction. The absorbance of 
the samples was measured at 517 nm and radical scavenging activity 
was expressed as percentage activity using the following formula. 
% radical scavenging activity
= (Control absorbance− sample absorbance)
⁄ (Control absorbance− sample absorbance)
× 100 
Anti-lipid peroxidation activity 
Anti-lipid peroxidation activity of R. graveolens leaf extracts were 
estimated by TBARS method [26]. 0.5 ml of egg homogenate and 
extracts (100μg) were made up to 1 ml with distilled water. 100μl of 
0.07M FeSO4 was added and incubated for 30 min at room 
temperature. To all test tubes 1.5 ml of acetic acid, 1.5 ml of TBA and 
50μl of TCA were added. Vortexed and kept in boiling water bath for 
1 hour. By adding 5 ml of butanol test tubes were centrifuged at 
3000 rpm for 10 min. Absorbance of supernatant was measured at 
530 nm and percentage was calculated using the formula,  
% Anti lipid peroxidation
= (1− Extract absorbance)
⁄ (Control absorbance) × 100 
Purification OF sPLA2 
sPLA2 from human pleural fluid (HPF) was purified by the modified 
method described by Vishwanath [27]. HPF was centrifuged at 10,000 
rpm for 10 min. Supernatant was separated and equal volume of 0.36N 
H2SO4 was added. The sample was kept on the stirrer overnight, 
centrifuged at 10,000 rpm for 10 min. Supernatant was dialyzed using 
7-8 KD cut off membrane against phosphate buffer (10 mM, pH 4.6). 
Dialyzed sample was kept on a water bath for 5 min at 60-70oC. The 
boiled sample was further centrifuged at 10,000 rpm for 10 min and 
the supernatant will be used as a source of sPLA2 
sPLA2 inhibition 
Inhibition of sPLA2 by agarose egg yolk plate method was done 
according to Gutierrez [28]. 1g of agarose was boiled in 100 ml of 0.1M 
Tris HCl (pH 7.4) contains 5 mM CaCl2. Add 6 drops of egg yolk agarose 
after it reached to room temperature. Stirred and poured into sterile 
petriplates and allowed to solidify. Make well using gel puncture and 
load 25μl HPF-PLA2 into the wells. Incubate the plates for overnight at 
37oC, measure the zone of clearance using normal scale carefully. Zone 
of HPF-PLA2 alone serves as control and the well without HPF-PLA2 
serves as a negative control. HPF-PLA2 pre-incubated with 50μg R. 
graveolens ethanol and aqueous extracts were used as test. Percentage 
of PLA2 inhibition was calculated using the formula. 
[(Control diameter− Test diameter) Control diameter⁄ ] × 100 
Inhibition of 5-lipoxygenase  
The Poly Morpho Nuclear Leukocytes (PMNLs) 5-lipoxigenase (5-
LOX) assay was performed according to the method published by 
Aharony and Stein [29]. 1 ml of standard reaction mixture contains 
100 mM phosphate buffer pH 7.4, 50µg of DDT, 200µg of ATP, 300µg 
of CaCl2, 150µg of arachidonic acid and PMNLs lipoxigenase (5µg). 
The reaction was carried out at room temperature. Absorbance was 
read for every 30 seconds up to 2 min at 234 nm using Shimadzu 
spectrophotometer. The enzyme activity was expressed as µgole of 
5-HETE formed/min/mg protein. The 5-lipoxigenase was subjected 
to the inhibition by R. graveolens extract (100-500 µg). The 
Quercetin, a known inhibitor of LOX, was used as a positive control. 
Inhibition of 15-lipoxygenase 
The enzyme assay was performed according to the method of Axelrod 
[30]. The standard reaction mixture for the 15-LOX assay (1.0 ml final 
volume) contained 100µg linoleic acid and soybean 15-lipoxygenase 
enzyme (5µg) in 200 mM borate buffer pH 9.0. The reaction was carried 
out at room temperature. The absorbance was measured continuously 
for 3 min at 234 nm. The enzyme activity was expressed as µg ole of 13-
HPODE formed/min/mg protein. For inhibition study, different 
concentrations (100-500 µg) of ethanol and aqueous extracts of R. 
graveolens were pre-incubated with 15-LOX for 5 min. The reaction was 
initiated by adding linoleic acid to the respective assay mixtures. 
Quercetin, a known inhibitor of LOX was used as a positive control. 
Neutralization of indirect hemolytic activity 
The indirect hemolytic activity of R. graveolens was measured as 
described by Boman and Kaletta [31]. The substrate was prepared 
by suspending 1 ml of packed fresh human RBC and 1 ml fresh hen 
egg yolk in 8 ml of PBS. Aqueous extract of R. graveolens was pre-
incubated with 30µg of PLA2 for 30 min at 37 °C. The substrate (1 
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ml) was added to the pre-incubated sample and allowed to react for 
45 min at 37ºC. The reaction was stopped by adding 9 ml of ice cold 
PBS and the suspension was mixed and centrifuged at 1,500 g for 20 
min. The released hemoglobin was read at 530 nm. The substrate 
with sPLA2 enzyme served as positive control. 
Statistical analysis 
The experimental results were presented as mean±SD of three 
determinations. The IC50 concentration was calculated using Graph 
pad version 5.0 USA.  
  
 
Fig. 1: Estimation of phenolics, flavonoids, saponins and 
alkaloids (%w/w) of R. graveolens extracts at 100µg. Data 
represents mean±SD (n=3) 
 
RESULTS 
The R. graveolens possesses anti-ulcer activity and promotes incision 
wound healing in mice [32] but the mechanism is unclear. The sPLA2 
enzyme is subjected to inhibition as a function of anti-inflammatory 
activity. Initially, different solvent extracts of R. graveolens were 
prepared and the phyto chemicals were estimated quantitatively 
and qualitatively. Total phenolics, flavonoids, saponins and alkaloids 
were estimated for all the extract. Ethanol extract of R. graveolens 
leaf has excellent phytochemical followed by water extract. Whereas 
hexane extract has very low phytochemicals (Fig.1). Among 
phytochemicals, phenols have higher concentration followed by 
flavonoids, saponins and alkaloids. 
Phytochemical separation of the extracts was carried out by Thin 
Layer Chromatography (TLC). Hexane: ethyl acetate solvent ratio 
(8:2) was found to be a good for the separation of the active 
constituents and the plant extract on the chromatogram was carried 
out. The TLC of different solvent extracts of R. graveolens shows 
different spots under UV light (fig. 2). Rf values of extracts spots 
separated in TLC were calculated and ethanol extract shows 
maximum spots between Rf values 0.228 to 0.906 (table. 1). 
 
 
Fig. 2: TLC of R. graveolens leaf extracts: a) Chloroform, b) 
Acetone, c) Ethanol, d) Methanol and e) Water extract
 
Table 1: The Thin layer chromatography retention factor of R. graveolens leaf extracts 
S. No. R. graveolens Extracts Number of spots  
 
Retention factor (Rf)  
 
1 chloroform 1 0.906 
2 acetone 4 0.967, 0.906,0.811, 0.717 
3 Ethanol 7 0.906, 0.811, 0.717, 0.517, 0.367, 0.228 
4 Methanol 3 0.967, 0.906, 0.111 
5 Water 4 0.689, 0.367,0.228, 0.111 
 
Antioxidant and anti-inflammatory activity of extracts of R. 
graveolens were estimated. The DPPH scavenging, reducing power, 
lipid peroxidation and superoxide scavenging activity of ethanol 
extract and aqueous extracts of R. graveolens showed 92.34/85.81%, 
89.7/75%, 80.8/61.8% and 78.9/69.21% respectively at 100 µg 
concentrations (fig. 3).  
 
 
Fig. 3: Estimation of DPPH scavenging, anti-lipid peroxidation, 
reducing power and superoxide scavenging activity of R. 
graveolens extracts at 100µg. Data represents mean±SD (n=3) 
To confirm the anti-inflammatory activity of R. graveolens ethanol and 
aqueous extract, the secretory PLA2 enzyme from Human Pleural Fluid 
(HPF) was subjected for inhibition. The ethanol extract inhibited sPLA2 
enzyme at 50µg concentration in egg yolk plate method followed by 
water extract. Percentage of HPF-PLA2 inhibition was 66.6% and 
46.6% for ethanol and water extract respectively (fig. 4). 
 
 
Fig. 4: Inhibition of sPLA2 by egg yolk plate method. The well 
contains 1) control 2) 25µg of HPF-PLA2 3) 25µg of HPF-PLA2 
and 50 µl ethanol extract 4) 25µg of HPF-PLA2 and 50 µl 
aqueous extract 
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The pro-inflammatory enzymes 5-LOX and 15-LOX activity was 
measured in terms of amounts of formation of 5-HETE and 13-
HPODE respectively. The ethanol extract of R. graveolens inhibited 
both the LOX enzymes in concentration dependent manner followed 
by aqueous extract. IC50 values of R. graveolens extracts for PMNLs 5-
LOX is 4.25, 5.15±0.05 µg/µl (fig. 5) and 15-LOX is 4.15, 4.66±0.05 
µg/µl (Fig.6) for ethanol and water extracts respectively.  
 
 
Fig. 5: Inhibition of 5-LOX by ethanol and aqueous extracts of R. 
graveolens at 500 µg. 1 ml of reaction mixture contains 100 mM 
phosphate buffer (pH 7.4), DDT (50µg), ATP (200µg), CaCl2 
(300µg), arachidonic acid (150µg) and 5-LOX (5µg). 




Fig. 6: Inhibition of 15-LOX by ethanol and aqueous extracts of 
R. graveolens at 500 µg. The reaction mixture contained linoleic 
acid (100µg) and 15-LOX (5µg) in 200 mM borate buffer (pH 
9.0). Absorbance measured at 234 nm by µgole of 5-HETE and 
13-HPODE formed/min/mg protein 
 
 
Fig. 7: Indirect hemolytic activity of R. graveolens leaf extract. 
The substrate contains 1 ml RBC, 1 ml egg yolk and 100 µg R. 
graveolens leaf extracts were pre incubated with 30µg HPF-
PLA2. The released hemoglobin was read at 530 nm 
The in situ hemolytic activity is an indirect way of measuring PLA2 
activity using egg yolk phospholipids dispersed as micelles together 
with washed erythrocytes. Ethanol extract inhibited the indirect 
hemolytic activity 66.8% and water extract 64.22% at 100µg 
concentrations (fig. 7). 
DISCUSSION 
Since ancient times, plants have been a veritable source of drugs. 
However, human tends to ignore the value of herbal medicine. 
Successive isolation of bio active compounds from plant material is 
mainly dependent on the type of solvent used in the extraction 
procedure. Phytochemical analysis of the chloroform, Acetone, 
Ethanol and water extracts of R. graveolens showed the presence of 
some phytochemical parameters like phenolics, flavanoids, saponins 
and alkaloids. Therefore, such screening experiments make a 
primary platform for further phytochemical and pharmacological 
studies that may open the possibility of finding new clinically 
effective anti-inflammatory compounds.  
The thin layer chromatographic study of the extract shows 
maximum spots in ethanol extract. This result supports that 
phytochemical content is high in ethanol extract of R. graveolens. 
Further, all solvent extracts were subjected to check the In vitro anti-
oxidant activity. R. gravoelens extracts found to scavenge hydroxyl 
radical and inhibited lipid peroxidation at lower concentration. 
These results strongly suggest the correlation between antioxidant 
activity and phytochemical contents of the extracts.  
The most NSAIDs target the either COX-1/2 or LOX enzymes or both 
the enzymes. Therefore the ethanol extracts of R. graveolens was 
checked for the two of the inflammatory enzymes Poly Morpho 
Nuclear Lymphocytes LOX (PMNLs 5-LOX) and soybean LOX (15-LOX). 
R. graveolens ethanolic and aqueous extracts might possess potent 
active principles which inhibits 5-LOX and 15-LOX enzyme. IC50 
values of ethanol and water extracts of R. graveolens were found to 
be 4.25, 5.15 µg/µl for 5-LOX and 4.15, 4.66±0.05 µg/µl respectively. 
The phytochemical and anti-oxidants derived from plants are 
potential interest in therapeutic intervention for chronic 
inflammatory disorders. They act either by inhibiting pro-
inflammatory enzymes (PLA2, COX and LOX) or by inhibition of 
cytokines (IL-1β, TNF-α) release and inhibition of mast cell 
degranulation that are known contributors to chronic inflammatory 
disorders. The sPLA2 enzyme catalyze rate limiting step in the 
production of pro-inflammatory eicosanoids and free radicals. The 
PLA2 catalyzed reaction is considered to be a significant pathway for 
reactive oxygen species (ROS), it turn activates PLA2 as well as lipid 
peroxidation and thereby augment the chronic inflammatory 
diseases to several folds [32]. Hence The PLA2 inhibition is 
legitimate in the neutralization of inflammation. The anti-oxidants 
such as flavonoids, retinoids and vitamin E and their potential 
benefit in intervention of inflammatory reactions arise if it inhibits 
the key enzyme PLA2 along with neutralizing the free radical 
generation reaction. Among the solvents ethanol exhibited the 
higher degree of sPLA2 inhibitory action. In the present study, we 
have established the anti-inflammatory activity of the ethanol 
extract of R. graveolens leaf by an egg yolk agar well diffusion 
method. The ethanol extracts of R. graveolens leaf shows sPLA2 
inhibition along with LOX inhibition and anti-oxidant activity at low 
concentration. 
CONCLUSION 
In the present day, anti-oxidative properties of plants extracts have 
become a great interest due to their possible uses as natural 
additives to replace synthetic ones and NSAIDs. The above data 
summarized that ethanol extracts of R. graveolens exhibited very 
good in-vitro HPF-PLA2 inhibition at very low concentration and the 
pro-inflammatory enzymes like 5-LOX and 15-LOX in concentration 
dependent manner. Although, the extract used in the assay is crude 
there is always a possibility of the cumulative effect, which may be 
the other reason for sPLA2 inhibition. However, several important 
questions remain open and further investigations are necessary to 
understand the mechanism underlying the effects of the extract and 
their active compound/s responsible for anti-inflammatory activity.  
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